Both in Pharmaceuticals
Amylyx Pharmaceuticals vs Parabilis Medicines
Over the past year AMLX returned −11.6% and PBLS returned −26.2%; their daily moves had a correlation of 0.60.
AMLX −11.6% PBLS −26.2%Growth of $1, one year, split-adjusted
| Metric | AMLX | PBLS |
|---|---|---|
| Price | $27.95 | $27.20 |
| Market cap | $3.51B | $3.36B |
| Today | −3.15% | −3.95% |
| 1 month | +0.6% | −10.2% |
| 6 months | +69.8% | — |
| Year to date | +131.4% | — |
| 1 year | +98.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −45239.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $250.8M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 112.3% | — |
| Short % of float | 13.7% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).